Enhancer Epigenetic Reprogramming

Enhancer Epigenetic Reprogramming is the process by which the chromatin state of distal regulatory elements known as enhancers is abnormally reconfigured in cancer cells, creating new active enhancers at locations that are normally silent, or conversely silencing enhancers that are normally active, thereby rewiring which genes receive strong transcriptional activation.

Enhancer Chromatin Signatures

Defining Active Enhancers

Active enhancers are typically marked by a characteristic combination of histone modifications distinct from those found at active promoters, along with high chromatin accessibility and binding by specific transcription factors and coactivator proteins that together enable the enhancer to boost transcription of its target gene.

Poised and Inactive Enhancer States

Enhancers can also exist in a poised state, primed for future activation but not currently driving transcription, or in a fully inactive state lacking the marks associated with either active or poised function. The transitions between these states form the basis of normal developmental gene regulation and are frequently disrupted during malignant transformation.

Patterns of Reprogramming in Cancer

De Novo Activation of Oncogenic Enhancers

Cancer cells frequently acquire newly active enhancers at genomic locations that are silent in the normal cell of origin, often positioned near genes that support proliferation, survival, or other malignant behaviors, effectively creating novel regulatory elements that did not previously drive expression of their target genes.

Silencing of Tumor-Suppressive Enhancers

Enhancers that normally support expression of genes involved in differentiation, growth restraint, or apoptosis can be silenced in cancer cells, removing a layer of positive regulation that would otherwise help maintain normal cellular behavior.

Super-Enhancer Formation

Cancer cells can develop unusually large and densely marked clusters of enhancer elements, known as super-enhancers, positioned near genes of central importance to the cancer cell's identity and survival, driving exceptionally high levels of expression of these critical target genes.

Mechanisms of Enhancer Reprogramming

Oncogenic Transcription Factor Recruitment

Transcription factors that become abnormally active or overexpressed in cancer cells can bind to new genomic locations and recruit the chromatin-modifying machinery needed to convert these sites into active enhancers, directly linking oncogenic signaling to enhancer reprogramming.

Genetic Alterations Creating New Enhancers

Point mutations can create new transcription factor binding motifs at previously inert genomic sequences, providing a direct genetic route to enhancer activation, as observed in recurrent noncoding mutations that generate binding sites for growth-associated transcription factors.

Structural Rearrangements and Enhancer Hijacking

Chromosomal rearrangements can relocate a strong, normally tissue-appropriate enhancer next to a different gene than it typically regulates, a phenomenon known as enhancer hijacking, effectively repurposing an existing active enhancer to drive inappropriate expression of a newly adjacent oncogene.

Functional Consequences

Establishment of Oncogenic Dependency

Genes driven by newly formed or hijacked enhancers, particularly super-enhancers, can become central to the survival of the cancer cell, creating a state of dependency in which disrupting the reprogrammed enhancer severely compromises the tumor cell's viability.

Loss of Normal Differentiation Programs

Silencing of enhancers that normally support lineage-specific differentiation genes contributes to the loss of normal cellular identity often observed in aggressive tumors, favoring a more plastic or primitive cellular state.

Detection Methods

Enhancer Chromatin Mapping

Genome-wide mapping of the histone modifications and accessibility patterns characteristic of active enhancers allows researchers to catalog the enhancer landscape of a tumor and compare it against the corresponding normal tissue to identify reprogrammed regulatory elements.

Three-Dimensional Contact Mapping

Because enhancers often act on distant target genes through physical chromatin looping, mapping three-dimensional chromatin contacts helps confirm which genes a newly identified or altered enhancer is actually regulating.

Clinical Relevance

Reprogrammed enhancers, particularly super-enhancers driving critical oncogenic dependencies, represent attractive therapeutic targets, since disrupting the specific transcriptional coactivators or chromatin-modifying enzymes required to sustain these elements can selectively impair cancer cell survival while sparing normal cells that do not share the same reprogrammed regulatory dependencies.